Goal Integration of Diabetes Self-Management Education and Psychosocial Support With Pharmacotherapy for Weight Loss in Adults With Type 2 Diabetes and Obesity

Despite a small overall reduction in rates of adult obesity between 2021 and 2023 ( 1 ), it is estimated that, by 2030, nearly half of all U.S. adults will have obesity with some variation across subpopulations ( 2 ). Because overweight and obesity increase the risk for type 2 diabetes ( 3 ), interventions to address weight management are essential components of the standards of care for type 2 diabetes prevention and management ( 4 ). The U.S. Preventive Services Task Force recommends that clinicians offer or refer adults with obesity to intensive multicomponent behavioral interventions that promote ≥5% weight loss on average ( 5 ). Weight loss can improve physiological disease, depressive symptoms, and physical health-related quality of life ( 6 ).